Subscribe to our Newsletters !!
On September 16, 2024, HiMedia Laboratories proudl
Particles in suspensions are abundant in biologica
Dräger India is proud to announce the launch of t
Husky Technologies™ is excited to announce a maj
Alembic Pharmaceuticals Limited (Alembic) today an
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Micr
China has affirmed beginning period human tests for two exploratory antibodies to battle the new coronavirus that killed more than 100,000 individuals around the world, state media Xinhua provided details regarding Tuesday.
The antibodies are being created by a Beijing-based unit of Nasdaq-recorded Sinovac Biotech, and by the Wuhan Institute of Biological Products, an offshoot of state-possessed China National Pharmaceutical Group.
In March, China gave the green-light for another clinical preliminary for a coronavirus immunization competitor created by military-upheld China’s Academy of Military Medical Sciences and HK-recorded biotech firm CanSino Bio, soon after U.S. tranquilize designer Moderna said it had started human tests for their immunization with the U.S. National Institutes of Health.
